Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2005
12/08/2005CA2565257A1 Thioether derivatives, their manufacture and use as pharmaceutical agents
12/08/2005CA2564884A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
12/08/2005CA2563819A1 Compounds and compositions as ppar modulators
12/08/2005CA2563466A1 Anti-cytokine heterocyclic compounds
12/07/2005EP1602373A1 Ocular hypotensive agent
12/07/2005EP1601671A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament
12/07/2005EP1601657A1 Pyrazole modulators of atp-binding cassette transporters
12/07/2005EP1601654A1 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides
12/07/2005EP1601653A1 Process for the production of substituted nicotinic acid esters
12/07/2005EP1601354A2 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
12/07/2005EP1458715B1 Novel compounds
12/07/2005EP1450800A4 SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
12/07/2005EP1399438B1 Novel heteroaryl derivatives, their preparation and use
12/07/2005EP1370258B1 Peptide deformylase inhibitors
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005CN1705661A Method for preparing risperidone
12/07/2005CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
12/07/2005CN1230435C Heteroaryl-substd. heterocycles
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
12/07/2005CN1230166C Gyrase inhibitors and uses thereof
12/06/2005US6972335 useful as highly specific, non-toxic anticancer therapeutics and provides methods of inhibiting multidrug resistant cells
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972290 Piperazine derivatives and their use as anti-inflammatory agents
12/06/2005US6972288 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
12/06/2005US6972287 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/06/2005US6972286 Oxazolidinones having a benzannulated 6- or 7-membered heterocycle
12/06/2005CA2173257C Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes
12/06/2005CA2160081C Manufacture of 4-aryl-2-perfluoroalkyl-3-oxazolin-5-one from arylglycine
12/06/2005CA2096528C Retroviral protease inhibitors
12/01/2005WO2005113551A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
12/01/2005WO2005113549A1 Substituted 2,5-diaminomethyl-1h-pyrroles
12/01/2005WO2005113537A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005WO2005113535A2 Pyrazinylmethyl lactam derivatives
12/01/2005WO2005113523A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/01/2005WO2005113522A1 Azole carboxamide inhibitors of bacterial type iii protein secretion systems
12/01/2005WO2005113519A1 Compounds and compositions as ppar modulators
12/01/2005WO2005113511A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005WO2005113504A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
12/01/2005WO2005113499A1 Indole compounds
12/01/2005WO2005113494A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
12/01/2005WO2005112938A2 Disalt inhibitors of il-12 production
12/01/2005WO2005112932A2 Raf modulators and methods of use
12/01/2005WO2005112925A1 Aryl sulfonamides
12/01/2005WO2005112923A2 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
12/01/2005WO2005112916A2 Bis-aryl sulfonamides
12/01/2005WO2005112913A1 Transthyretin stabilization
12/01/2005WO2005112630A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof
12/01/2005WO2005082848A3 Method for preparing pyrrolidine oximes
12/01/2005WO2005075467A3 Crystalline forms of zolmitriptan
12/01/2005WO2005042516A3 Ligands of melanocortin receptors and compositions and methods related thereto
12/01/2005WO2004101544A8 Benzyl sulfonamide derivatives as androgen receptor antagonists
12/01/2005WO2004085401A8 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
12/01/2005US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use
12/01/2005US20050267182 Urea derivatives as FLT-3 modulators
12/01/2005US20050267179 Novel thioether derivatives
12/01/2005US20050267178 Novel benzylether derivatives
12/01/2005US20050267177 Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267160 arthritis, allergic contact dermatitis, psoriasis, asthma, rheumatoid arthritis, or stroke; using producing coronary vasodilation without significant peripheral vasodilation
12/01/2005US20050267152 Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/01/2005US20050267148 Benzimidazole derivative
12/01/2005US20050267146 3-(4-Heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005US20050267122 Ansamycins having improved pharmacological and biological properties
12/01/2005US20050267119 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
12/01/2005US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
12/01/2005US20050267111 Pharmaceutical compositions and methods for use
12/01/2005US20050267110 Propane-1, 3-dione derivative
12/01/2005US20050267106 For therapy of respiratory complaints
12/01/2005US20050267104 Acyloxymethylcarbamate prodrugs of oxazolidinones
12/01/2005US20050267097 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
12/01/2005US20050267094 glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens
12/01/2005US20050267073 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/01/2005US20050267043 Novel inhibitors of hepatitis C virus NS3 protease
12/01/2005CA2567506A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
12/01/2005CA2567483A1 Pyrazinylmethyl lactam derivatives
12/01/2005CA2567352A1 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
12/01/2005CA2566937A1 Substituted 2,5-diaminomethyl-1h-pyrroles
12/01/2005CA2566923A1 2-((hetero) aryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
12/01/2005CA2566688A1 Transthyretin stabilization
12/01/2005CA2566460A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use thereof
12/01/2005CA2565200A1 Raf modulators and methods of use
12/01/2005CA2564429A1 Compounds and compositions as ppar modulators
11/2005
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
11/30/2005EP1600440A1 Indole derivative compounds and drugs containing the compounds as the active ingredient
11/30/2005EP1600166A1 Skeletal muscle protecting agent
11/30/2005EP1599878A1 Optical recording materials having high storage density
11/30/2005EP1599471A1 Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents
11/30/2005EP1599470A1 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them
11/30/2005EP1599468A1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
11/30/2005EP1599465A1 Substituted n-aryl nitrogen heterocycles
11/30/2005EP1599455A1 4-(3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butane acid derivatives and related compounds as ppar modulators for treating diabetes of type 2 and atherosclerosis
11/30/2005EP1599454A2 Diarylcycloalkyl derivatives, method for their production and their use as medicaments
11/30/2005EP1599453A1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis
11/30/2005EP1599452A1 3-(2-phenyl-oxazol-4-yl methoxy) cyclohexylmethoxy acetic acid derivatives and related compounds used as ppar modulators for treating type 2 diabetes and arteriosclerosis
11/30/2005EP1599447A1 Ligands that modulate lxr-type receptors
11/30/2005EP1599206A2 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity
1 ... 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 ... 647